Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans
Clinical trial NCT04506645 · COMPLETED
Trial details
- NCT number
- NCT04506645
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-12-14
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.